Alpha Teknova, Inc. (TKNO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 5.24 |
| Open | 5.2 |
| Day High | 5.27 |
| Day Low | 4.93 |
| 52-Week High | 6.68 |
| 52-Week Low | 1.91 |
| Volume | 400,781 |
| Average Volume | 151,519 |
| Market Cap | 276.65M |
| PE | -16.65 |
| EPS | -0.31 |
| Moving Average 50 Days | 3.92 |
| Moving Average 200 Days | 3.95 |
| Change | -0.08 |
Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
GlobeNewswire Inc.
Feb 05, 2026 9:01 PM GMT
HOLLISTER, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnosti
Teknova to Report Third Quarter 2025 Financial Results on November 6, 2025
GlobeNewswire Inc.
Oct 28, 2025 8:01 PM GMT
HOLLISTER, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnosti
Teknova to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire Inc.
Jul 24, 2025 8:05 PM GMT
HOLLISTER, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnosti